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Abstract Severely decreased ejection-fraction is an
established risk-factor for worse outcome after cardiac sur-
gery. We compare outcomes of off-pump coronary artery
bypass grafting (OPCAB) and on-pump CABG (ONCABG)
in patients with severely compromised EF. From 2004
to 2009, 478 patients with a decreased EF B35% under-
went myocardial-revascularization. Patients received either
OPCAB (n = 256) or ONCABG (n = 222). Propensity
score (PS), including 50 preoperative risk-factors, was used
to balance characteristics between groups. PS adjusted
logistic regression analysis was performed to assess mortality
and major adverse cardiac and cerebrovascular events
(MACCE). A composite endpoint for major non-cardiac
complications such as respiratory failure, renal failure,
rethoracotomy was applied. Complete revascularization
(CR) was assumed when the number of distal anastomoses
was larger than that of diseased vessels. There was no dif-
ference for mortality (2.3 vs. 4.1%; PS-adjusted odds ratio
(PS-OR) = 1.05; p = 0.93) and MACCE (13.7 vs. 17.6%;
PS-OR = 1.22; p = 0.50) including myocardial-infarction
(1.4 vs. 4.9%; PS-OR = 0.39; p = 0.26), low cardiac output
(2.3 vs. 4.7%; PS-OR = 0.75; p = 0.72) and stroke (2.3 vs.
2.7%; PS-OR = 0.69; p = 0.66). OPCAB patients presented
with a trend to less frequent occurrence of the non-cardiac
composite (12.1 vs. 22.1%; PS-OR = 0.54; p = 0.059)
including renal dysfunction (PAOR = 0.77; 95% CI
0.31–1.9; p = 0.57), bleeding (PAOR = 0.42; 95% CI
0.14–1.20; p = 0.10) and respiratory failure (PAOR = 0.39;
95% CI 0.05–3.29; p = 0.39). The rate of complete revas-
cularization was similar (92.2 vs. 92.8%; PS-OR = 0.75;
p = 0.50). OPCAB in patients with severely decreased EF is
safe and feasible. It may even benefit these patients in regard
to non-cardiac complications and does not come at cost of
less complete revascularization.
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Introduction
Surgical revascularization for patients with severe left
ventricular dysfunction remains a challenge. Various
studies report an increased peri-operative mortality and
morbidity for these patients [1, 2]. In the EuroScore risk
stratification system (http:\\www.euroscore.org), decreased
ventricular function is an independent risk factor for worse
outcome after cardiac surgery.
Conventional CABG is performed with cardio-pulmon-
ary bypass (CBP), which is associated with complications
such as renal dysfunction, stroke, and other neurological
complications [3] as well as an increased risk for a sys-
temic inflammatory response syndrome (SIRS) [4]. The
compromised outcomes for patients undergoing CABG
with ventricular dysfunction may be in part linked to the
use of CPB and the application of cardioplegic solutions to
achieve cardiac arrest [4, 5].
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Off-pump coronary artery bypass surgery (OPCAB) has
a comparable risk-adjusted mortality and morbidity as
on-pump CABG [6–8]. Current reports suggest OPCAB to
be superior for high-risk patients [9]. For patients with
severe ventricular dysfunction, only few reports are avail-
able [10–13].
In this study, we evaluate safety and feasibility of
OPCAB surgery in patients with a decreased ejection
fraction (B35%).
Materials and methods
From 2004 to 2009, 3,981 patients underwent surgical
revascularization at our institution. Of these patients, 478
presented with severe ventricular dysfunction and an
ejection fraction B35%. Of these, 53% (n = 256) received
off-pump surgery (OPCAB) and 47% (n = 222) conven-
tional CABG. All data were collected prospectively and the
study was approved by an institutional review board (IRB),
including a waiver of informed consent. Indication for
surgery was: elective (66.8 vs. 64.4%; p = 0.63), urgent
(32.4 vs. 27.7%; p = 0.27), and emergent (5.5 vs. 3.2%;
p = 0.26) respectively. The EuroScore (http:\\www.Euro
Score.org) was used for preoperative risk stratification. The
ejection fraction was documented by preoperative trans-
thoracic echocardiography and was confirmed with in a left
ventriculogram, which was obtained during coronary
angiography to define the target vessels. In addition, these
data were correlated to intraoperative trans-esophageal
echocardiography (TOE) in all patients as TOE is part of
our OPCAB practice (Table 1).
Surgical technique
CABG was performed with administration of standardized
cardio-pulmonary bypass techniques and proximal anasto-
mosis was done with cross-clamping of the aorta. OPCAB
procedures were performed as previously described [14].
Briefly, heparin was given to achieve an active clotting
time (ACT) in excess of 350 s. Pacemaker wires were
placed epicardially, before a stabilizer (Octopus4 Tissue
Stabilizer, Medtronic, Minneapolis, USA) was applied for
target vessel exposal. Shunt insertion was (ClearView
Intracoronary Shunt, Medtronic, Minneapolis, USA) was
routinely performed to maintain distal perfusion during
anastomosis and a mister blower (Guidant, Indianapolis,
USA) with CO2 and water was used to clear the surgical
field. If no T-Graft was performed and whenever a proxi-
mal anastomosis was necessary, it was performed in ‘no
touch’ fashion using the heartstring device (HEART-
STRINGTM Proximal Seal System, Guidant, Indianapolis,
USA). After LIMA to LAD grafting, the right coronary
system was approached, and finally the circumflex territory
was addressed. Standardized ultrasound flow measurement
(MediStim QuickFit) was carried out in all patients [15].
Completeness of revascularization
The anticipated complete revascularization was based on
the defined target vessels reported on the preoperative
angiography. This information was compared to the per-
formed grafts documented in the postoperative surgical
report and was assumed to be complete when the total
number of distal grafts was higher than that of diseased
vessels reported on the preoperative angiography [7].
Statistical analysis
Endpoints analyzed are mortality and major adverse car-
diac and cerebrovascular events (MACCE). A composite
endpoint including major non-cardiac adverse events such
Table 1 Preoperative characteristics and demographics
Parameter OPCAB
n = 256
CABG
n = 222
p value
Age (years) 64 ± 10 63 ± 9 0.27
Male (%) 81 85 0.22
Female (%) 19 15 0.23
EuroScore 4.6 ± 1.0 4.9 ± 1.0 0.06
BMI (kg/m2) 27 ± 4 27 ± 4 0.54
Elective (%) 66.8 64.4 0.63
Urgent (%) 32.4 27.7 0.27
Emergent (%) 5.5 3.2 0.26
Sinus rhythm (%) 91.6 98.6 0.002
Atrial fibrillation (%) 4.9 0.9 0.03
Pacemaker (%) 3.5 0.5 0.04
No. of diseased vessels 2.79 ± 0.45 2.95 ± 0.23 0.001
1-vessel disease (%) 1.5 2.3 0.74
2-vessel disease (%) 18.4 11.7 0.56
3-vessel disease (%) 80.1 86.0 0.09
Left main disease (%) 28.5 23.9 0.26
CCS 1 (%) 7.6 7.2 1.00
CCS 2 (%) 29.4 28.4 0.83
CCS 3 (%) 42.2 36.9 0.28
CCS 4 (%) 20.9 27.5 0.11
NYHA 1 (%) 51.5 49.5 0.70
NYHA 2 (%) 26.4 22.1 0.32
NYHA 3 (%) 19.5 17.1 0.55
NYHA 4 (%) 2.6 11.3 0.001
Redo surgery (%) 5.5 4.5 0.68
EF ejection fraction, BMI body mass index, CCS Canadian Cardio-
vascular Society Angina Classification, NYHA New York Heart
Association
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as respiratory failure, renal failure, and rethoracotomy for
bleeding was created. Crossover patients were analyzed on
an ‘Intention-to-treat’ basis.
Continuous data are presented as mean ± standard
deviation and are compared using the Mann–Whitney test.
Categorical data are presented as number and percentage
and are compared using the Chi-square test or Fisher’s
exact test where appropriate. Odds ratios with 95% confi-
dence intervals are computed using univariate logistic
regression. A propensity score (PS) was calculated using
logistic regression with preoperative variables to balance
characteristics between both groups. In case of missing
values in preoperative variables were replaced using
regression methods. The PS then was divided into quintiles
and analyzed as a categorical variable. PS-adjusted logistic
regression analysis was performed to assess binary end-
points and two-way analysis of variance for continuous
endpoints.
The data-set of preoperative variables for the PS score
included preoperative patient characteristics such as car-
diovascular risk-factors and co-morbidities including
cerebral-vascular events, peripheral artery disease (PAD),
chronic-obstructive pulmonary-disease (COPD), and renal
disease. These parameters were defined in accordance
with the definitions of the EuroScore Risk Stratification
system (http:\\www.euroscore.org); Cerebrovascular dis-
ease defined as the history of transient ischemic attacks
(TIA) or stroke, COPD defined with the long-term use of
bronchodilators or steroids for lung disease, renal disease
as creatinine levels [200 lmol/l and PAD defined as
one or more of claudication, carotid occlusion or [50%
stenosis, previous or planned intervention on the abdominal
aorta, limb arteries or carotids. Diabetes mellitus was
defined as type 2 insulin-dependant diabetes (Table 2).
Cardiac-related preoperative conditions were: preceding
myocardial-infarction (MI), recent MI within 3 months
prior to surgery, preceding cardiogenic-shock, congestive
heart-failure, instable angina pectoris, arrhythmias, number
of diseased coronary-vessels, previous CABG, elective,
urgent/or emergent presentation, previous PTCA, previous
stent implantation, NYHA class, CCS class, logistic
EuroScore and others. All analyses were performed using
SPSS 18 (SPSS Inc., Chicago, IL, USA). p values \0.05
are assumed to be statistically significant.
Results
Patient demographics
OPCAB patients and CABG patients were comparable
with regards to mean age, gender, and EuroScore. In brief,
OPCAB patients presented with significantly more
peripheral artery disease (18.3 vs. 11.3%; p = 0.039) and
diabetes (35.2 vs. 22.5%; p = 0.003), whereas patients
undergoing on-pump CABG suffered more frequently from
chronic obstructive pulmonary disease (COPD) (4.7 vs.
10.4%; p = 0.022) and presented more frequently with
instable angina (14.7 vs. 27.5%; p = 0.005). The number
of patients presenting with significant left main disease
(28.5 vs. 23.9%; p = 0.26) or for redo surgery (5.5 vs.
4.5%; p = 0.68) was comparable in both groups.
Table 2 Risk factors
and co-morbidities
PAD peripheral artery disease,
COPD chronic obstructive
pulmonary disease,
MI myocardial infarction,
IABP intra aortic balloon pump
Parameter OPCAB n = 256 CABG n = 222 p value
Hypercholesterolemia (%) 65.0 71.6 0.20
Hypertension (%) 58.1 50.4 0.10
Positive family history (%) 32.0 32.0 1.00
Diabetes 35.2 22.5 0.003
Smoking (%) 61.0 59.5 0.76
Adiposities (%) 48.8 41.0 0.09
PAD (%) 18.3 11.3 0.039
COPD (%) 4.7 10.4 0.022
Recent myocardial infarction (\90 days) (%) 20.7 31.5 0.009
Previous MI ([90 days) (%) 48.0 59.9 0.01
Previous cardiogenic shock ([90 days) (%) 14.7 17.1 0.56
Cerebrovascular disease (%) 2.0 0.0 0.06
Previous syncope (%) 5.6 1.4 0.03
Renal disease (%) 4.2 4.5 1.00
Instable angina (%) 14.7 27.5 0.005
IABP preoperative (%) 18.8 25.2 0.09
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Outcome data before and after propensity
adjustment (Table 3)
OPCAB patients had a comparable mortality rate (2.3 vs.
4.1%; odds ratio (OR) = 0.57; 95% CI 0.20–1.62; p =
0.29) and similar MACCE (13.7 vs. 17.6%; OR = 0.74;
95% CI 0.44–1.22; p = 0.24) such as myocardial infarc-
tion (1.4 vs. 4.1%; OR = 0.34; 95% CI 0.71–1.58; p =
0.17) and low cardiac output (2.3 vs. 4.7%; OR = 0.48;
95% CI 0.11–2.23; p = 0.35). The composite of non-car-
diac adverse events was lower in the OPCAB group (12.1
vs. 22.1%; OR = 0.49; 95% CI 0.30–0.80; p = 0.004).
This was mainly driven by the reduced occurrence of
bleeding complications (6.3 vs. 9.0%; OR = 0.67; 95% CI
0.34–1.33; p = 0.26), renal dysfunction (4.3% vs. 8.1%;
OR = 0.50; 95% CI 0.23–1.10; p = 0.08 and respiratory
failure (1.1 vs. 4.2%; OR = 0.27; 95% CI 0.33–2.12;
p = 0.21). The beneficial effect of OPCAB in regard to
respiratory complications was also reflected in a lower rate
of pleural effusions and pneumothorax (3.5 vs. 7.5%;
OR = 0.25; 95% CI 0.16–1.25; p = 0.13) as well as in the
overall shorter time to extubation (\12 h) (58.9 vs. 36.9%;
OR = 2.44; 95% CI 1.63–3.65; p \ 0.001) indicating a
more straight-forward postoperative course. Neurological
outcomes including the occurrence of stroke were
comparable in both groups (2.3 vs. 2.7%; OR = 0.86; 95%
CI 0.28–2.72; p = 0.80).
After propensity score adjustment, OPCAB patients still
displayed comparable mortality (propensity-adjusted odds
ratio (PAOR) = 1.05; 95% CI 0.30–3.63; p = 0.93) and
MACCE (PAOR = 1.22; 95% CI 0.68–2.22; p = 0.50). In
regard to the non-cardiac complications including renal
dysfunction (PAOR = 0.77; 95% CI 0.31–1.9; p = 0.57),
bleeding (PAOR = 0.42; 95% CI 0.14–1.20; p = 0.10)
and respiratory failure (PAOR = 0.39; 95% CI 0.05–3.29;
p = 0.39), the beneficial effect of OPCAB remained
visible. Similarly, a trend towards less occurrence of the
non-cardiac composite was still detectable for OPCAB,
however, failed to achieve statistical significance after
adjustment (PAOR = 0.0.54; 95% CI 0.29–1.02; p =
0.059).
Intra-operative data and completeness
of revascularization (Table 4)
The need for intra-operative implantation of an IABP was
similar in both groups (5.9 vs. 7.2%; p = 0.32). Conver-
sion to CPB became necessary in 5.9% of all OPCAB
patients. If converted, the operation was continued in
beating-heart fashion.
Table 3 Crude outcome and propensity adjusted outcome
Parameter OPCAB
n = 256
CABG
n = 222
OR CI 95% p value PA OR PA CI 95% PA
p value
Mortality (%) 2.3 4.1 0.57 0.20–1.62 0.29 1.05 0.30–3.63 0.93
Neurological events (central) (%) 2.3 2.7 0.86 0.28–2.72 0.80 0.69 0.14–3.54 0.66
Neurological events (peripheral) (%) 1.2 0.5 2.62 0.27–25.37 0.40 1.14 0.07–18.84 0.93
Re-thoracotomy for bleeding (%) 6.3 9.0 0.67 0.34–1.33 0.26 0.42 0.14–1.20 0.10
Myocardial infarction (%) 1.4 4.1 0.34 0.71–1.58 0.17 0.39 0.07–2.01 0.26
Low cardiac output (%) 2.3 4.7 0.48 0.11–2.23 0.35 0.75 0.15–3.70 0.72
Graft occlusion (%) 0.0 1.9 – – 0.32 – – 0.32
Cardiac tamponade (%) 0.0 0.5 – – 1.00 – – 1.00
Arrhythmia (%) 6.9 3.7 1.91 0.64–5.67 0.24 2.15 0.63–7.30 0.22
IABP postop (%) 0.0 2.7 – – 0.01 – – 0.01
Renal dysfunction (%) 4.3 8.1 0.50 0.23–1.10 0.08 0.77 0.31–1.90 0.57
No ventilation (%) 1.0 0.9 1.12 0.16–7.99 0.91 6.96 0.91–53.11 0.61
Ventilation \12 h (%) 58.9 36.9 2.44 1.63–3.65 <0.001 1.39 0.79–2.43 0.25
Prolonged ventilation [24 h (%) 8.3 11.7 0.69 0.36–1.33 0.27 1.59 0.70–3.42 0.27
Respiratory failure (%) 1.1 4.2 0.27 0.33–2.12 0.21 0.39 0.05–3.29 0.39
Pleural effusions/pneumothorax (%) 3.5 7.5 0.25 0.16–1.25 0.13 0.56 0.19–1.66 0.30
Sinus rhythm (%) 87.4 93.7 0.47 0.22–0.97 0.04 0.52 0.23–1.18 0.12
Atrial fibrillation (%) 9.1 5.9 1.60 0.72–3.57 0.24 1.90 0.80–4.48 0.15
MACCE (%) 13.7 17.6 0.74 0.45–1.22 0.24 1.22 0.68–2.20 0.50
Non-cardiac composite (%) 12.1 22.1 0.49 0.30–0.80 0.004 0.54 0.29–1.02 0.059
OR odds ratio, 95% CI confidence interval 95%, PA OR propensity adjusted OR, PA 95% CI propensity adjusted 95% CI, PA p value propensity
adjusted p value, IABP Intra-aortic balloon pump, MACCE major adverse cardiac and cerebrovascular events
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OPCAB patients presented with a lower mean number
of the diseased coronary vessels (2.79 ± 0.45 vs. 2.95 ±
0.23; p = 0.001) and also received a lower number of total
distal grafts (3.42 ± 1.05 vs. 3.85 ± 0.81; p \ 0.001). For
similar proportions in both groups, revascularization was
possible without necessity of any proximal anastomosis
(9.8 vs. 10.8%; p = 0.42). Complete revascularization was
achieved in similar levels for both groups (92.2 vs. 92.8%;
p = 0.50).
Discussion
OPCAB is safe and feasible in high-risk patients with
severely decreased EF requiring myocardial revasculari-
zation. Mortality and MACCE are comparable to patients
undergoing on-pump surgery. Furthermore, our results
highlight that OPCAB patients presented with a trend to
less non-cardiac complications, including renal dysfunction
and postoperative bleeding. These patients also appeared to
have decreased respiratory complications, which was also
reflected in an overall faster extubation indicating a
straighter postoperative course.
Although a recent prospective randomized trial identi-
fied OPCAB to have no advantage in low-risk patients [16],
it appears to be the superior method of revascularization in
high-risk patients [9, 17, 18].
Our results are in line with Stamou et al. [17] who
recently reviewed 513 high-risk patients. Of these patients,
228 presented with an EF \34% either undergoing
on-pump CABG (n = 102) or off-pump CABG (n = 126).
They identified OPCAB to have a lower mortality and a
comparable event-free survival. The authors concluded that
off-pump CABG can be performed with a reasonably low
morbidity and lower mortality in high-risk patients. In
comparison to our study, Stamou et al. [17] did not spe-
cifically focus on the outcome of patients with low EF, but
on patients with a generally high-risk profile, including
factors such as renal-failure, recent myocardial-infarction,
cerebrovascular disease and advanced age.
Among 1,398 evaluated high-risk patients, Al-Ruzzeh
et al. [18] identified OPCAB patients to have significantly
less major postoperative complications. Puskas and
colleagues [9] compared 14,766 patients and found that
OPCAB is associated with a lower operative mortality and
disproportionately benefits high-risk patients.
Very similar to our report, Sharoni et al. recently
evaluated 353 patients with an EF \35% who either
underwent OPCAB (n = 144) or on-pump (n = 209)
coronary artery bypass surgery. Both groups did not differ
significantly in regard to major postoperative complication
rates or mortality suggesting OPCAB to be applicable for
patients with impaired left ventricular function. The
authors showed an increase in the use of OPCAB over
time, without any impact on morbidity or mortality [19].
This is in line with our results and is well comparable to
the evolution of OPCAB as the standard of care at many
institutions.
Cardiopulmonary bypass may have a damaging effect
on the myocardium. Pathophysiologically, this is reflected
by an extended degree of inflammatory response [4] and
myocardial injury [20, 21], especially if the CPB run is
prolonged [10]. The activation of numerous inflammatory
mediators may compromise myocardial performance, par-
ticularly if the LV function is already severely impaired
[22, 23]. Moreover, due to the transient change of the
ventricular geometry and the ischemic cardiac arrest during
CPB, the coronary collateral-flow supplying ischemic areas
of the myocardium, is limited [23]. Therefore, OPCAB
may be beneficial for patients with severely decreased EF
Table 4 Intraoperative data
Parameter OPCAB n = 256 CABG n = 222 p value
CPB conversion (%) 5.9 – –
CPB time (min) – 107 ± 46 –
Aortic x-clamp time (min) – 48 ± 27 –
Arterial grafts per patient 1.49 ± 0.98 1.35 ± 0.80 0.28
LIMA (%) 96.9 95.0 0.67
RIMA (%) 30.9 26.6 0.73
Radial artery (%) 16.0 3.6 <0.001
SVG per patient 1.93 ± 1.28 2.50 ± 1.10 <0.001
Use of SVG (%) 81.6 89.2 0.037
Total number of proximal anastomoses 1.12 ± 0.61 1.44 ± 0.64 0.05
Total number of grafts per patient 3.42 ± 1.05 3.85 ± 0.81 <0.001
No of diseased vessels 2.79 ± 0.45 2.95 ± 0.23 0.001
Completeness of revascularization (%) 92.2 92.8 0.50
IABP intraoperative (%) 5.9 7.2 0.32
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with regards to an overall better cardiac recovery and
straighter postoperative course.
A standardized OPCAB approach in high-risk patients
does not come at a price of less complete revascularization.
This is an important aspect that has been highlighted to be
a crucial predictor for the long-term outcome [7, 8], but has
also been reported to be a major argument against OPCAB
[11, 24, 25]. Our findings are supported by Puskas et al. [8]
who demonstrated feasibility of complete revascularization
using OPCAB.
Due to its retrospective nature and non-randomized
design, all established disadvantages apply. Although bal-
ancing scores constitute the most rigorous methods avail-
able for apples-to-apples investigation of causal effects on
outcome in the retrospective, nonrandomized setting, they
are not equal to randomized clinical trials and they cannot
account for unknown variables affecting outcome that are
not correlated strongly with measured variables [26]. In
addition, our results lack the force of numbers and certainly
a higher level of significance may have been achieved, had
we had a larger patient cohort to analyze. Although the
total number of diseased vessels was included in the pro-
pensity adjustment, a certain bias may apply, since OPCAB
patients had significantly less diseased vessels. Finally, the
study period was quite long with most CABG patients
being from the early part of the study, whereas the major
part of OPCAB patients was from the later part of the study
period.
In conclusion, OPCAB in high-risk patients with
severely decreased EF is safe and should not deter surgeons
from performing the OPCAB approach in this subset of
patients. It comes with similar mortality and MACCE, may
even benefit the patients in regard to non-cardiac compli-
cations and is not at cost of less complete revascularization.
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